Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy

World Journal of Urology

Volumn 33, Issue 3, 2015, Pages 335-341

  Hurel, Sophie ^a   Rouprêt, Morgan ^b   Seisen, Thomas ^b   Comperat, Eva ^b   Phé, Véronique ^b   Droupy, Stéphane ^c   Audenet, François ^b   Pignot, Géraldine ^d   Cathelineau, Xavier ^e   Guy, Laurent ^f   Cussenot, Olivier ^g   Ouzzane, Adil ^h   Bozzini, Gregory ^h   Nison, Laurent ^h   Ruffion, Alain ⁱ   Colin, Pierre ^j  

^a CHU CÔTE DE NACRE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c NÎMES UNIVERSITY HOSPITAL   (France)

^d BICÊTRE HOSPITAL   (France)

^e Academic Department of Urology Montsouris Institute   (France)

^f UNIVERSITÉ CLERMONT AUVERGNE   (France)

^g HÔPITAL TENON   (France)

^h UNIV LILLE   (France)

ⁱ UNIVERSITÉ LYON 1   (France)

^j Génerale de Santé ^*  (France)

more..

Author keywords

Nephroureterectomy; Prognosis; Renal pelvis; Survival; Ureter; Urothelial carcinoma

Indexed keywords

AGED; CARCINOMA, TRANSITIONAL CELL; CLINICAL TRIAL; COMPLICATION; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; KAPLAN MEIER METHOD; KIDNEY; KIDNEY FAILURE; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEPHRECTOMY; PREOPERATIVE PERIOD; PROCEDURES; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; URETER; UROLOGIC NEOPLASMS; UROLOGIC SURGERY;

AGED; CARCINOMA, TRANSITIONAL CELL; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY; MALE; MIDDLE AGED; NEPHRECTOMY; PREOPERATIVE PERIOD; PROGNOSIS; REGRESSION ANALYSIS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URETER; UROLOGIC NEOPLASMS; UROLOGIC SURGICAL PROCEDURES;

EID: 84939886259     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-014-1311-8     Document Type: Article

References (26)

1. Visser O, Adolfsson J, Rossi S, Verne J, Gatta G, Maffezzini M et al (2012) Incidence and survival of rare urogenital cancers in Europe. Eur J Cancer 48:456–464
2. Raman JD, Messer J, Sielatycki JA, Hollenbeak CS (2010) Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005. BJU Int 107:1059–1064
3. Colin P, Koenig P, Ouzzane A, Berthon N, Villers A, Biserte J et al (2009) Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int 104:1436–1440
4. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG (1998) Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52:594–601
5. Bader MJ, Sroka R, Gratzke C, Seitz M, Weidlich P, Staehler M et al (2009) Laser therapy for upper urinary tract transitional cell carcinoma: indications and management. Eur Urol 56:65–71
6. Matin SF, Margulis V, Kamat A, Wood CG, Grossman HB, Brown GA et al (2010) Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer 116:3127–3134
7. Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R et al (2011) Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the upper tract urothelial carcinoma collaboration. BJU Int 108:1286–1291
8. Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester R, Burger M et al (2013) European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol 63:1059–1071
9. Roupret M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR et al (2013) Prediction of cancer-specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized post-operative nomogram using decision curve analysis. J Urol 189:1662–1669
10. Sobin L, Godspodarowicz M, Wittekind C (2009) Renal pelvis and ureter. In: International Union Against Cancer (ed) TNM classification of malignant tumours. Urological tumours. Wiley, New York, pp 258–261
11. Mostofi FK, Sorbin LH, Torloni H (1973) International histological classification of tumours: histological typing of urinary bladder tumours. World Health Organization ed
12. Lane BR, Smith AK, Larson BT, Gong MC, Campbell SC, Raghavan D et al (2010) Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 116:2967–2973
13. Schips L, Lipsky K, Zigeuner R, Salfellner M, Winkler S, Langner C et al (2003) Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: a single-center experience of 683 patients. Urology 62:1024–1028
14. Lee CT, Katz J, Fearn PA, Russo P (2002) Mode of presentation of renal cell carcinoma provides prognostic information. Urol Oncol 7:135–140
15. Raman JD, Shariat SF, Karakiewicz PI, Lotan Y, Sagalowsky AI, Roscigno M et al (2011) Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy? Urol Oncol 29:716–723
16. Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ et al (2012) Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy. BJU Int 110:E7–E13. doi:10.1111/j.1464-410X.2011.10792.x
17. Ouzzane A, Colin P, Xylinas E, Pignot G, Ariane MM, Saint F et al (2011) Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. Eur Urol 60:1258–1265
18. Favaretto RL, Shariat SF, Savage C, Godoy G, Chade DC, Kaag M et al (2012) Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int 109:77–82
19. Williams AK, Kassouf W, Chin J, Rendon R, Jacobsen N, Fairey A et al (2013) Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma. Urol Oncol 31:1161–1165
20. Hung PH, Shen CH, Chiu YL, Jong IC, Chiang PC, Lin CT et al (2009) The aggressiveness of urinary tract urothelial carcinoma increases with the severity of chronic kidney disease. BJU Int 104:1471–1474
21. Xylinas E, Rink M, Margulis V, Clozel T, Lee RK, Comploj E et al (2013) Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy. BJU Int 112:453–461
22. Brien JC, Shariat SF, Herman MP, Ng CK, Scherr DS, Scoll B et al (2010) Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol 184:69–73
23. Sakano S, Matsuyama H, Kamiryo Y, Hayashida S, Yamamoto N, Kaneda Y et al (2013) Risk group stratification based on preoperative factors to predict survival after nephroureterectomy in patients with upper urinary tract urothelial carcinoma. Ann Surg Oncol 20:4389–4396
24. Ito K, Kuroda K, Asakuma J, Hamada S, Tachi K, Tasaki S et al (2014) Preoperative risk factors for extraurothelial recurrence in patients with ureteral cancer treated with radical nephroureterectomy. J Urol. doi:10.1016/j.juro.2013.12.048
25. Lughezzani G, Sun M, Perrotte P, Shariat SF, Jeldres C, Budaus L et al (2010) Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the surveillance, epidemiology, and end results database. Urology 75:321–327
26. Krabbe LM, Westerman ME, Bagrodia A, Gayed BA, Khalil D, Kapur P et al (2014) Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a review of the literature. Urol Oncol 32(54):e19–e26